0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paclitaxel Drug-Eluting Balloon Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15E14974
Home | Market Reports | Health| Health Conditions| Cancer
Global Paclitaxel Drug Eluting Balloon Market Research Report 2023
BUY CHAPTERS

Global Paclitaxel Drug-Eluting Balloon Market Research Report 2025

Code: QYRE-Auto-15E14974
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Paclitaxel Drug-Eluting Balloon Market

The global market for Paclitaxel Drug-Eluting Balloon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
North American market for Paclitaxel Drug-Eluting Balloon is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Paclitaxel Drug-Eluting Balloon is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Paclitaxel Drug-Eluting Balloon include Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic, Philips, Eurocor, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Paclitaxel Drug-Eluting Balloon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel Drug-Eluting Balloon.
The Paclitaxel Drug-Eluting Balloon market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Paclitaxel Drug-Eluting Balloon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel Drug-Eluting Balloon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Paclitaxel Drug-Eluting Balloon Market Report

Report Metric Details
Report Name Paclitaxel Drug-Eluting Balloon Market
Segment by Type
  • Balloon-Only Coating
  • Drug-Coated Balloon
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic, Philips, Eurocor, Yinyi Biotech, Lepu Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Paclitaxel Drug-Eluting Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Paclitaxel Drug-Eluting Balloon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Paclitaxel Drug-Eluting Balloon Market report?

Ans: The main players in the Paclitaxel Drug-Eluting Balloon Market are Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic, Philips, Eurocor, Yinyi Biotech, Lepu Medical Technology

What are the Application segmentation covered in the Paclitaxel Drug-Eluting Balloon Market report?

Ans: The Applications covered in the Paclitaxel Drug-Eluting Balloon Market report are Peripheral Artery Disease, Coronary Artery Disease

What are the Type segmentation covered in the Paclitaxel Drug-Eluting Balloon Market report?

Ans: The Types covered in the Paclitaxel Drug-Eluting Balloon Market report are Balloon-Only Coating, Drug-Coated Balloon

Recommended Reports

Balloon Catheter Markets

Drug-Eluting Devices

Coronary and Peripheral Intervention

1 Paclitaxel Drug-Eluting Balloon Market Overview
1.1 Product Definition
1.2 Paclitaxel Drug-Eluting Balloon by Type
1.2.1 Global Paclitaxel Drug-Eluting Balloon Market Value Comparison by Type (2024 VS 2031)
1.2.2 Balloon-Only Coating
1.2.3 Drug-Coated Balloon
1.3 Paclitaxel Drug-Eluting Balloon by Application
1.3.1 Global Paclitaxel Drug-Eluting Balloon Market Value by Application (2024 VS 2031)
1.3.2 Peripheral Artery Disease
1.3.3 Coronary Artery Disease
1.4 Global Paclitaxel Drug-Eluting Balloon Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Drug-Eluting Balloon Revenue 2020-2031
1.4.2 Global Paclitaxel Drug-Eluting Balloon Sales 2020-2031
1.4.3 Global Paclitaxel Drug-Eluting Balloon Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Paclitaxel Drug-Eluting Balloon Market Competition by Manufacturers
2.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Manufacturers (2020-2025)
2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Paclitaxel Drug-Eluting Balloon, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Product Type & Application
2.7 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Date of Enter into This Industry
2.8 Global Paclitaxel Drug-Eluting Balloon Market Competitive Situation and Trends
2.8.1 Global Paclitaxel Drug-Eluting Balloon Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Paclitaxel Drug-Eluting Balloon Players Market Share by Revenue
2.8.3 Global Paclitaxel Drug-Eluting Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Paclitaxel Drug-Eluting Balloon Market Scenario by Region
3.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2020-2031
3.2.1 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2020-2025
3.2.2 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2026-2031
3.3 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2020-2031
3.3.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2020-2025
3.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2026-2031
3.4 North America Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.4.1 North America Paclitaxel Drug-Eluting Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2031)
3.4.3 North America Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2031)
3.5.3 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Region
3.6.1 Asia Pacific Paclitaxel Drug-Eluting Balloon Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Region (2020-2031)
3.6.3 Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Drug-Eluting Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2031)
3.7.3 Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Drug-Eluting Balloon Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2031)
3.8.3 Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2031)
4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2020-2025)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2026-2031)
4.1.3 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2031)
4.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2020-2031)
4.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2020-2025)
4.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2026-2031)
4.2.3 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2020-2031)
4.3 Global Paclitaxel Drug-Eluting Balloon Price by Type (2020-2031)
5 Segment by Application
5.1 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2031)
5.1.1 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2020-2025)
5.1.2 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2026-2031)
5.1.3 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2020-2031)
5.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2020-2031)
5.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2020-2025)
5.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2026-2031)
5.2.3 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2020-2031)
5.3 Global Paclitaxel Drug-Eluting Balloon Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Company Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.3.4 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Cook Medical
6.4.1 Cook Medical Company Information
6.4.2 Cook Medical Description and Business Overview
6.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolio
6.4.5 Cook Medical Recent Developments/Updates
6.5 Cardionovum
6.5.1 Cardionovum Company Information
6.5.2 Cardionovum Description and Business Overview
6.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolio
6.5.5 Cardionovum Recent Developments/Updates
6.6 Aachen Resonance
6.6.1 Aachen Resonance Company Information
6.6.2 Aachen Resonance Description and Business Overview
6.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolio
6.6.5 Aachen Resonance Recent Developments/Updates
6.7 QT Vascular
6.7.1 QT Vascular Company Information
6.7.2 QT Vascular Description and Business Overview
6.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.7.4 QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolio
6.7.5 QT Vascular Recent Developments/Updates
6.8 Biotronic
6.8.1 Biotronic Company Information
6.8.2 Biotronic Description and Business Overview
6.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolio
6.8.5 Biotronic Recent Developments/Updates
6.9 Philips
6.9.1 Philips Company Information
6.9.2 Philips Description and Business Overview
6.9.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Philips Paclitaxel Drug-Eluting Balloon Product Portfolio
6.9.5 Philips Recent Developments/Updates
6.10 Eurocor
6.10.1 Eurocor Company Information
6.10.2 Eurocor Description and Business Overview
6.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolio
6.10.5 Eurocor Recent Developments/Updates
6.11 Yinyi Biotech
6.11.1 Yinyi Biotech Company Information
6.11.2 Yinyi Biotech Description and Business Overview
6.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolio
6.11.5 Yinyi Biotech Recent Developments/Updates
6.12 Lepu Medical Technology
6.12.1 Lepu Medical Technology Company Information
6.12.2 Lepu Medical Technology Description and Business Overview
6.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolio
6.12.5 Lepu Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Drug-Eluting Balloon Industry Chain Analysis
7.2 Paclitaxel Drug-Eluting Balloon Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Drug-Eluting Balloon Production Mode & Process Analysis
7.4 Paclitaxel Drug-Eluting Balloon Sales and Marketing
7.4.1 Paclitaxel Drug-Eluting Balloon Sales Channels
7.4.2 Paclitaxel Drug-Eluting Balloon Distributors
7.5 Paclitaxel Drug-Eluting Balloon Customer Analysis
8 Paclitaxel Drug-Eluting Balloon Market Dynamics
8.1 Paclitaxel Drug-Eluting Balloon Industry Trends
8.2 Paclitaxel Drug-Eluting Balloon Market Drivers
8.3 Paclitaxel Drug-Eluting Balloon Market Challenges
8.4 Paclitaxel Drug-Eluting Balloon Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Paclitaxel Drug-Eluting Balloon Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Paclitaxel Drug-Eluting Balloon Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Paclitaxel Drug-Eluting Balloon Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Paclitaxel Drug-Eluting Balloon Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Paclitaxel Drug-Eluting Balloon Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Paclitaxel Drug-Eluting Balloon, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Product Type & Application
 Table 12. Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Paclitaxel Drug-Eluting Balloon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Drug-Eluting Balloon as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Paclitaxel Drug-Eluting Balloon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Paclitaxel Drug-Eluting Balloon Sales by Region (2020-2025) & (K Units)
 Table 18. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2020-2025)
 Table 19. Global Paclitaxel Drug-Eluting Balloon Sales by Region (2026-2031) & (K Units)
 Table 20. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2026-2031)
 Table 21. Global Paclitaxel Drug-Eluting Balloon Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2020-2025)
 Table 23. Global Paclitaxel Drug-Eluting Balloon Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2026-2031)
 Table 25. North America Paclitaxel Drug-Eluting Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 27. North America Paclitaxel Drug-Eluting Balloon Sales by Country (2026-2031) & (K Units)
 Table 28. North America Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Paclitaxel Drug-Eluting Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Type (2020-2025)
 Table 51. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Type (2026-2031)
 Table 52. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2020-2025)
 Table 53. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2026-2031)
 Table 54. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2020-2025)
 Table 57. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2026-2031)
 Table 58. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Application (2020-2025)
 Table 61. Global Paclitaxel Drug-Eluting Balloon Sales (K Units) by Application (2026-2031)
 Table 62. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2020-2025)
 Table 63. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2026-2031)
 Table 64. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Paclitaxel Drug-Eluting Balloon Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2020-2025)
 Table 67. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2026-2031)
 Table 68. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Paclitaxel Drug-Eluting Balloon Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Paclitaxel Drug-Eluting Balloon Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. B. Braun Company Information
 Table 81. B. Braun Description and Business Overview
 Table 82. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. B. Braun Paclitaxel Drug-Eluting Balloon Product
 Table 84. B. Braun Recent Developments/Updates
 Table 85. Cook Medical Company Information
 Table 86. Cook Medical Description and Business Overview
 Table 87. Cook Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cook Medical Paclitaxel Drug-Eluting Balloon Product
 Table 89. Cook Medical Recent Developments/Updates
 Table 90. Cardionovum Company Information
 Table 91. Cardionovum Description and Business Overview
 Table 92. Cardionovum Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cardionovum Paclitaxel Drug-Eluting Balloon Product
 Table 94. Cardionovum Recent Developments/Updates
 Table 95. Aachen Resonance Company Information
 Table 96. Aachen Resonance Description and Business Overview
 Table 97. Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Aachen Resonance Paclitaxel Drug-Eluting Balloon Product
 Table 99. Aachen Resonance Recent Developments/Updates
 Table 100. QT Vascular Company Information
 Table 101. QT Vascular Description and Business Overview
 Table 102. QT Vascular Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. QT Vascular Paclitaxel Drug-Eluting Balloon Product
 Table 104. QT Vascular Recent Developments/Updates
 Table 105. Biotronic Company Information
 Table 106. Biotronic Description and Business Overview
 Table 107. Biotronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biotronic Paclitaxel Drug-Eluting Balloon Product
 Table 109. Biotronic Recent Developments/Updates
 Table 110. Philips Company Information
 Table 111. Philips Description and Business Overview
 Table 112. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Philips Paclitaxel Drug-Eluting Balloon Product
 Table 114. Philips Recent Developments/Updates
 Table 115. Eurocor Company Information
 Table 116. Eurocor Description and Business Overview
 Table 117. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Eurocor Paclitaxel Drug-Eluting Balloon Product
 Table 119. Eurocor Recent Developments/Updates
 Table 120. Yinyi Biotech Company Information
 Table 121. Yinyi Biotech Description and Business Overview
 Table 122. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product
 Table 124. Yinyi Biotech Recent Developments/Updates
 Table 125. Lepu Medical Technology Company Information
 Table 126. Lepu Medical Technology Description and Business Overview
 Table 127. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product
 Table 129. Lepu Medical Technology Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Paclitaxel Drug-Eluting Balloon Distributors List
 Table 133. Paclitaxel Drug-Eluting Balloon Customers List
 Table 134. Paclitaxel Drug-Eluting Balloon Market Trends
 Table 135. Paclitaxel Drug-Eluting Balloon Market Drivers
 Table 136. Paclitaxel Drug-Eluting Balloon Market Challenges
 Table 137. Paclitaxel Drug-Eluting Balloon Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Paclitaxel Drug-Eluting Balloon
 Figure 2. Global Paclitaxel Drug-Eluting Balloon Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Paclitaxel Drug-Eluting Balloon Market Share by Type: 2024 & 2031
 Figure 4. Balloon-Only Coating Product Picture
 Figure 5. Drug-Coated Balloon Product Picture
 Figure 6. Global Paclitaxel Drug-Eluting Balloon Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Paclitaxel Drug-Eluting Balloon Market Share by Application: 2024 & 2031
 Figure 8. Peripheral Artery Disease
 Figure 9. Coronary Artery Disease
 Figure 10. Global Paclitaxel Drug-Eluting Balloon Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Paclitaxel Drug-Eluting Balloon Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Paclitaxel Drug-Eluting Balloon Sales (2020-2031) & (K Units)
 Figure 13. Global Paclitaxel Drug-Eluting Balloon Average Price (US$/Unit) & (2020-2031)
 Figure 14. Paclitaxel Drug-Eluting Balloon Report Years Considered
 Figure 15. Paclitaxel Drug-Eluting Balloon Sales Share by Manufacturers in 2024
 Figure 16. Global Paclitaxel Drug-Eluting Balloon Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Paclitaxel Drug-Eluting Balloon Players: Market Share by Revenue in Paclitaxel Drug-Eluting Balloon in 2024
 Figure 18. Paclitaxel Drug-Eluting Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Paclitaxel Drug-Eluting Balloon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2020-2031)
 Figure 21. North America Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2031)
 Figure 22. United States Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2020-2031)
 Figure 25. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2020-2031)
 Figure 33. China Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Paclitaxel Drug-Eluting Balloon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Paclitaxel Drug-Eluting Balloon by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Paclitaxel Drug-Eluting Balloon by Type (2020-2031)
 Figure 52. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Paclitaxel Drug-Eluting Balloon by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Paclitaxel Drug-Eluting Balloon by Application (2020-2031)
 Figure 55. Global Paclitaxel Drug-Eluting Balloon Price (US$/Unit) by Application (2020-2031)
 Figure 56. Paclitaxel Drug-Eluting Balloon Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart